- Home
- SNY vs RMBS Comparison
SNY vs RMBS Comparison
Compare SNY & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- RMBS
- Stock Information
- Founded
- SNY 1994
- RMBS 1990
- Country
- SNY France
- RMBS United States
- Employees
- SNY N/A
- RMBS N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- RMBS Semiconductors
- Sector
- SNY Health Care
- RMBS Technology
- Exchange
- SNY Nasdaq
- RMBS Nasdaq
- Market Cap
- SNY 116.5B
- RMBS N/A
- IPO Year
- SNY N/A
- RMBS 1997
- Fundamental
- Price
- SNY $49.31
- RMBS $65.00
- Analyst Decision
- SNY Buy
- RMBS Strong Buy
- Analyst Count
- SNY 2
- RMBS 4
- Target Price
- SNY $62.50
- RMBS $78.25
- AVG Volume (30 Days)
- SNY 2.0M
- RMBS 880.7K
- Earning Date
- SNY 07-24-2025
- RMBS 07-28-2025
- Dividend Yield
- SNY 3.24%
- RMBS N/A
- EPS Growth
- SNY 39.56
- RMBS N/A
- EPS
- SNY 5.45
- RMBS 1.91
- Revenue
- SNY $48,817,552,946.00
- RMBS $605,417,000.00
- Revenue This Year
- SNY $3.39
- RMBS $26.07
- Revenue Next Year
- SNY $7.05
- RMBS $12.64
- P/E Ratio
- SNY $9.04
- RMBS $33.95
- Revenue Growth
- SNY N/A
- RMBS 30.13
- 52 Week Low
- SNY $45.80
- RMBS $37.43
- 52 Week High
- SNY $60.12
- RMBS $69.15
- Technical
- Relative Strength Index (RSI)
- SNY 49.10
- RMBS 70.49
- Support Level
- SNY $47.64
- RMBS $61.99
- Resistance Level
- SNY $48.46
- RMBS $64.90
- Average True Range (ATR)
- SNY 0.72
- RMBS 1.74
- MACD
- SNY 0.16
- RMBS 0.26
- Stochastic Oscillator
- SNY 52.21
- RMBS 94.61
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.